Pages that link to "Item:Q959231"
From MaRDI portal
The following pages link to Responder identification in clinical trials with censored data (Q959231):
Displaying 14 items.
- Detecting an interaction between treatment and a continuous covariate: a comparison of two approaches (Q1020054) (← links)
- Sufficient conditions for treatment responders to have longer survival than non-responders (Q1314709) (← links)
- Nonlinear predictive directions in clinical trials (Q2157508) (← links)
- Diagnosis-group-specific transitional care program recommendations for 30-day rehospitalization reduction (Q2247498) (← links)
- Regularized outcome weighted subgroup identification for differential treatment effects (Q2803485) (← links)
- A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies (Q2827203) (← links)
- (Q4991194) (← links)
- Subgroup identification by recursive segmentation (Q5036362) (← links)
- Efficient screening of predictive biomarkers for individual treatment selection (Q6094206) (← links)
- Optimal subgroup selection (Q6183867) (← links)
- Subgroup analysis using Bernoulli‐gated hierarchical mixtures of experts models (Q6189827) (← links)
- Estimating individual treatment effects by gradient boosting trees (Q6627236) (← links)
- Model-based recursive partitioning for subgroup analyses (Q6632722) (← links)
- Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data (Q6652603) (← links)